To better assess the contribution of the SUMO-1 modification pathway to the Tpr-induced senescence phenotype in cancer cells, we performed in parallel RNAi knockdown of Tpr, SUMO-1 and combined SUMO-1 and Tpr. Here, TPR is linked to cancer.